Sanguine Infra Tech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-12-2024
- Paid Up Capital ₹ 0.10 M
as on 02-12-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 103.00%
(FY 2022)
- Profit 567.47%
(FY 2022)
- Ebitda 586.17%
(FY 2022)
- Net Worth 38.65%
(FY 2022)
- Total Assets 40.60%
(FY 2022)
About Sanguine Infra Tech
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Digvijay Kudtarkar, Teja Kudtarkar, and Abhijit Kudtarkar serve as directors at the Company.
- CIN/LLPIN
U45209MH2014PTC257408
- Company No.
257408
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sanguine Infra Tech Private Limited offer?
Sanguine Infra Tech Private Limited offers a wide range of products and services, including Construction Service, Civil Contractors, Real Estate Services, Real Estate Developer, Investment Service, Mutual Fund Services.
Who are the key members and board of directors at Sanguine Infra Tech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Digvijay Kudtarkar  | Director | 21-Aug-2014 | Current |
| Teja Kudtarkar | Director | 08-Sep-2023 | Current |
| Abhijit Kudtarkar | Director | 21-Aug-2014 | Current |
Financial Performance and Corporate Structure Insights of Sanguine Infra Tech.
Sanguine Infra Tech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 103% increase. The company also saw a substantial improvement in profitability, with a 567.47% increase in profit. The company's net worth Soared by an impressive increase of 38.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanguine Infra Tech?
In 2020, Sanguine Infra Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanguine Infra Tech?
Sanguine Infra Tech has a workforce of 8 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanguine Infra Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Infra Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
